We observed that cancer mutations accumulate in critical regions of these proteins that fully thwart PTEN’s tumor-suppressive activities while promoting PI3Kα′s oncogenicity (Jang et al., 2021; Jang et al., 2023a). The gene discussed is PTEN; the disease is cancer.